Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Independence Vote a Matter of ‘When, Not If’

Scottish leader Nicola Sturgeon and British Prime Minister…
Read more

China Was Preparing Coronaviruses for WW3

Reports have shown that China was preparing coronavirus for…
Read more

Catholics Defy Vatican Gay Union Ban

Some Catholics are moving forward in their intentions to…
Read more